Tirzepatide 20mg Pen

Tirzepatide is a dual GIP and GLP-1 receptor agonist (marketed as Mounjaro) that improves blood sugar control, reduces appetite and supports sustainable weight loss.

Our Tirzepatide 20mg pen is a pre-loaded pen designed to last 4-8 weeks. Doctor-supervised and delivered to you in Cape Town.

Benefits

• Improves blood sugar control
• Reduces appetite
• Supports sustainable weight loss
• Dual GIP and GLP-1 receptor action

What's included

• Consultation with our Doctor
• Premium quality peptides
• Delivered straight to you in Cape Town

To ensure safe and effective treatment, baseline blood tests are required before starting Tirzepatide. Blood tests are billed separately. Book a telephonic consultation via 074 604 5555.

How to administer

1. Consultation. Attend a doctor consultation and complete baseline blood work before starting.
2. Delivery. Receive your pre-loaded Tirzepatide pen delivered to you in Cape Town.
3. Training. Complete 1:1 training on your first visit so you can self-administer at home.
4. Administer. Self-administer once weekly subcutaneous injection as prescribed.
5. Review. Track weight, appetite and blood sugar through the protocol and review with your doctor.

Learn more

• Peptide Therapy in Cape Town: Complete Guide

Frequently Asked Questions

What is Tirzepatide (Mounjaro)?

Tirzepatide is a dual GIP and GLP-1 receptor agonist originally developed for type 2 diabetes. It works by improving insulin sensitivity, slowing gastric emptying and reducing appetite, leading to sustainable weight loss.

How much weight can I expect to lose?

Results vary by individual. Clinical studies have shown average weight loss of 15-20% of body weight over 72 weeks. Your doctor will set realistic expectations based on your health profile.

Are there any side effects?

The most common side effects are mild nausea, reduced appetite and digestive changes, especially in the first few weeks. These typically improve as your body adjusts. All protocols are doctor-supervised.

Who is Tirzepatide suitable for?

Tirzepatide is suitable for adults with a BMI of 27+ who are looking for medically supervised weight management. A consultation and baseline blood work are required before starting.

How is it administered?

It is a once-weekly subcutaneous injection using a pre-loaded pen. We provide 1:1 training on your first visit so you can self-administer at home.

Evidence and Research

• In the SURMOUNT-1 trial, participants on the 15mg Tirzepatide weekly dose lost an average of 20.9% of body weight over 72 weeks compared to 3.1% on placebo (Jastreboff et al., N Engl J Med, 2022).
• Tirzepatide is a dual GIP and GLP-1 receptor agonist, which differs from single-pathway agonists like semaglutide and is associated with stronger metabolic effects in head-to-head trials (Frias et al., N Engl J Med, 2021).
• Gradual titration is standard practice to reduce gastrointestinal side effects, which are most common in the first 4 to 8 weeks.

"Tirzepatide is the most effective metabolic weight loss tool I have worked with, but it is a medication, not a supplement. The clients who do best are the ones who respect the titration schedule and show up for bloodwork."

Chloe Nefdt, RN (SANC), IVgo founder